I
n pregnancy, the maternal immune system (including innate and adaptive immunity) makes elaborate adjustments to endure the embryo's expression of paternal antigens and to protect the embryo from attacks by invading pathogens such as bacteria or viruses. 1 As the predominant innate immune cells during gestation, natural killer (NK) cells have been proven to mediate the establishment of maternal-fetal immune tolerance and to initiate appropriate defenses against infections. 2 Tim-3, a member of the T-cell immunoglobulin and mucin domain proteins, has emerged as a key molecule in both innate and adaptive responses and represents a promising novel therapeutic target. 3, 4 The expression of Tim-3 has been shown to associate with the maturation or activation of NK cells, and the surrounding immune microenvironment of NK cells also exerts some influence on Tim-3 expression. Accordingly, Tim-3 mediates the differential regulation of NK cell functions in specific physiologic or pathologic processes, playing a beneficial or detrimental role in immune status. It remains largely unknown how Tim-3 that is expressed on NK cells controls their functions during pregnancy.
The recent published data in this issue of Cellular and Molecular Immunology demonstrate the existence of a particular NK cell subset-Tim-3-expressing NK cell at the maternal-fetal interface. 5 We characterized Tim-3 + NK cell phenotypes and revealed how Tim-3 affects the activity of these innate immune cells in the context of pregnancy. Compared with Tim-3 − decidual NK (dNK) cells, Tim-3 + dNK cells produced more T helper 2 (Th2)-typical cytokine, interleukin-4 (IL-4), but less Th1-typical cytokine, tumor necrosis factor-α (TNF-α). Perforin expression, an indicator of the cytotoxic activity of NK cells, was also significantly reduced in Tim-3 + dNK cells. Importantly, we showed a remarkably decreased percentage of Tim-3 + dNK cells in patients suffering miscarriages. In addition, a disturbed cytokine profile and increased cytotoxicity were observed in Tim-3 + dNK cells, but not in Tim-3 − dNK cells from patients suffering miscarriages. These findings indicate that Tim-3 functions as a regulatory receptor on NK cells by reducing their cytotoxicity and modulating cytokine production in the context of gestation, which is similar to that in cancer and chronic infections. Tim-3 expressed on NK cells attenuates cellmediated antitumor effects, serving a facilitating role in cancer. 6, 7 Thus, Tim-3 blockade to reverse NK cell-mediated function could develop Tim-3-targeted tumor immune therapy. 8 Similarly, the expression of Tim-3 on NK cells in gestation is conducive to the establishment and maintenance of maternal-fetal immune tolerance. Moreover, our unpublished data show that expanded Tim-3 + NK cells in maternal peripheral blood display immune-suppressive activity, including high-level production of anti-inflammatory cytokines and the induction of regulatory T (Treg) cell differentiation. Consistent with the downregulated expression of Tim-3 on dNK cells in miscarriages, Tim-3 expression on peripheral NK (pNK) cells was also compromised and was accompanied by impaired immune-suppressive activity. More importantly, Tim-3 blockade notably increased embryo resorption and led to dysfunctional NK cells in both the periphery and decidua. Combined with the above data, decreased expression of Tim-3 on NK cells may serve as a promising biological marker during pregnancy to predict the occurrence of miscarriage.
In addition to the capacity to induce local immune tolerance, dNK cells can transform into active defenders once pathogens attack the embryo. To effectively clear the pathogens, it is necessary to promote inflammatory cytokine production by dNK cells and their cytotoxicity. However, excessive inflammatory response and cytotoxicity may change the immune microenvironment of the embryo, even breaking the state of specific immune tolerance in decidua, which results in a great risk of pregnancy failure. 9 Therefore, an intricate balance between immune tolerance and immune clearance is of great importance during pregnancy. Our study shows that the activation of Tim-3 signaling obviously suppressed the inflammatory response and the enhanced cytotoxicity of dNK cells induced by lipopolysaccharide (LPS) stimulation. Similar observations could be obtained in the mouse model of LPSinduced endotoxic shock in which the Tim-3 pathway was negatively correlated with NK cell activity but Tim-3 blockade restored NK cell function and promoted the prognosis of sepsis. 10, 11 Collectively, Tim-3 expression renders the functional plasticity of NK cells in decidua, playing roles in physiological and pathological processes in gestation.
Ndhlovu et al. 12 demonstrated that Tim-3 marks human NK cell maturation. In our study, we examined the expression of Tim-3 on NK cells in maternal peripheral blood and decidua. Approximately 90% of pNK cells are Tim-3 positive while the percentage of Tim-3 + dNK cells is~60%. As we know, the majority of pNK cells in pregnancy are mature CD56 dim NK cells, but the dNK cells are mainly immature CD56 bright NK cells. 13 Moreover, we analyzed the published microarray data and found that Tim-3 expression gradually increased during the process in which NK cells differentiated from CD34 + cells to mature NK cells. 14 Collectively, we speculated that Tim-3 might be a maturation marker of NK cells. In addition, the expression of Tim-3 on NK cells is influenced by other factors. Our unpublished data demonstrated that Tim-3 on pNK cells was strikingly upregulated during the first trimester in normal pregnancy due to the typical Th2 polarization signal IL-4/STAT6 and physiological concentrations of progesterone, which suggests that Tim-3 expression on NK cells is affected by the change in the maternal immune system and pregnancy-associated hormones, characterizing the process of gestation. Furthermore, it was reported that Tim-3 expression is up-regulated on NK cells in cancers and chronic HBV or HCV infections. 7, 15, 16 These data indicate that Tim-3 expression on NK cells varies according to the surrounding immune microenvironment. The differential expression of Tim-3 on pNK cells and dNK cells in pregnancy is a good example for understanding the regulator function of Tim-3 on NK cells, including the maturation stage of NK cells and immune status. The expression level of Tim-3 on NK cells might be closely correlated with their functions. NK cells isolated from healthy donors express Tim-3 in their resting state. After activation with several cytokines, including IL-2, IL-12, IL-15 and IL-18, NK cells express a significantly higher level of Tim-3 and display the enhanced ability to produce INF-γ. 12 On the other hand, overexpressed Tim-3 leads to dysfunctional NK cells with attenuated cytotoxicity and INF-γ production, which can be seen in cancers. The phenomenon in which overexpressed Tim-3 is negatively associated with NK cell function is also observed in chronic viral (HBV, HCV and HIV) infections, 17 contributing to immune escape and disease progression. In the context of pregnancy, the whole maternal immune system is adjusted to establish immune tolerance towards the fetus by various mechanisms. NK cells in both maternal peripheral blood and decidua shape their immunesuppressing phenotype via the upregulation of Tim-3 expression. To conclude, the regulated Tim-3 expression level is closely related to NK cell function.
We demonstrated that expanded Tim-3 + NK cells with immune-tolerant phenotypes are conducive to accepting the embryo and protecting it from various infections in early pregnancy (Figure 1) . The revealed role of Tim-3 on maternal NK cells brings new insights into the mechanism of pregnancy immune tolerance. More importantly, the Tim-3 + NK cells defined in our study may serve as promising biological markers during early pregnancy to predict the occurrence of miscarriage. New treatment targeting Tim-3 may provide a breakthrough in therapy for patients with recurrent miscarriage.
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